Ventas, Inc.
VTR Large CapReal Estate · REIT - Healthcare Facilities
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Ventas, Inc. en bref
Ventas, Inc. (VTR) is currently trading at 71,22 € with a market capitalization of 34,6 Md €. The trailing P/E ratio stands at 148.38x, with a forward P/E of 96.39x. The 52-week range spans from 53,90 € to 79,47 €; the current price is 10.4% below the yearly high. Year-over-year revenue growth stands at +21.9%. The net profit margin stands at 4.26%.
💰 Dividende
Ventas, Inc. pays an annual dividend of 1,75 € per share, representing a yield of 2.45%. The payout ratio stands at 356.36%. The elevated payout ratio reflects a mature dividend policy.
📊 Avis des analystes
20 analystes évaluent Ventas, Inc. (VTR) au consensus : Acheter. L'objectif de cours moyen est de 84,69 €, soit un potentiel de +18.92% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 75,05 € à 95,99 €.
Ventas, Inc. : la thèse d'investissement en détail
Ventas, Inc. (VTR) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Revenue is growing at a healthy 21.9% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 18.92% upside from current levels — analyst sentiment is firmly constructive.
Le scénario baissier
With a net margin of just 4.26%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.
À surveiller
- The forward P/E of 96.39x is meaningfully below the trailing 148.38x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Forte croissance du CA de 21.9% sur un an
- Consensus des analystes : Buy
- Rendement du dividende solide de 2.45%
- Free cash flow positif
- –Faible rentabilité (marge 4.26%)
- –Multiple de valorisation élevé (P/E 148.38x)
- –Actuellement jugée surévaluée
Aperçu technique
Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (5.5%).
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Immobilier stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Ventas, Inc.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
